Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2D | Q13557 | 6/20 | 0.67 |
| ▸ | ABL1 | P00519 | 4/20 | 0.65 |
| ▸ | BCR | P11274 | 4/20 | 0.65 |
| ▸ | PRKCA | P17252 | 1/20 | 0.65 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.65 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.62 |
| ▸ | CDK2 | P24941 | 4/20 | 0.60 |
| ▸ | CDK1 | P06493 | 2/20 | 0.60 |
| ▸ | SMG1 | Q96Q15 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | CDK4 | P11802 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.60 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.60 |
| ▸ | XBP1 | P17861 | 1/20 | 0.60 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.60 |
| ▸ | CCND1 | P24385 | 1/20 | 0.60 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | MTOR | P42345 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3513988 | 0.89 | CAMK2D (0.75) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL2327902 | 0.88 | CAMK2D (0.67) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL27822604 | 0.85 | MAPT (0.64) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL3511698 | 0.85 | CAMK2D (0.63) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL14254007 | 0.84 | CAMK2D (0.65) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL2333459 | 0.84 | KDR (0.61) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL5733933 | 0.84 | CAMK2D (0.71) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL7809816 | 0.84 | CSNK2A1 (0.68) | CAMK2DABL1BCRPRKCAPRKCD | |
| SCHEMBL3513566 | 0.84 | MAPT (0.66) | CAMK2DABL1BCRPRKCAPRKCD | |
| Hydrochloric Acid SCHEMBL3514073 | 0.83 | CSNK2A1 (0.67) | CAMK2DABL1BCRPRKCAPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100137309-A1 | FUNGICIDES PHENYL-PYRIMIDNYL-AMINO DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-06-03 | — | — | US | claimed |
| EP-2155713-A1 | FUNGICIDES PHENYL-PYRIMDINYL-AMINO DERIVATIVES | Bayer CropScience SA (FR) | 2010-02-24 | — | — | EP | claimed |
| WO-2008138992-A1 | FUNGICIDES PHENYL-PYRIMDINYL-AMINO DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2008-11-20 | — | — | WO | claimed |
| EP-0672042-B1 | PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | NOVARTIS AG (CH) | 2006-05-03 | — | — | EP | claimed |
| US-5705502-A | Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof | NOVARTIS CORPORATION (US) | 1998-01-06 | — | — | US | claimed |
| EP-0672042-A1 | PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Novartis AG (CH) | 1995-09-20 | — | — | EP | claimed |
| WO-1995009851-A1 | PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | CIBA-GEIGY AG (CH) | 1995-04-13 | — | — | WO | claimed |
| US-20100137309-A1 | FUNGICIDES PHENYL-PYRIMIDNYL-AMINO DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-06-03 | — | — | US | disclosed |
| EP-2155713-A1 | FUNGICIDES PHENYL-PYRIMDINYL-AMINO DERIVATIVES | Bayer CropScience SA (FR) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008138992-A1 | FUNGICIDES PHENYL-PYRIMDINYL-AMINO DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2008-11-20 | — | — | WO | disclosed |
| EP-0672042-B1 | PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | NOVARTIS AG (CH) | 2006-05-03 | — | — | EP | disclosed |
| US-5705502-A | Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof | NOVARTIS CORPORATION (US) | 1998-01-06 | — | — | US | disclosed |
| EP-0672042-A1 | PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Novartis AG (CH) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995009851-A1 | PHARMACOLOGICALLY ACTIVE PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | CIBA-GEIGY AG (CH) | 1995-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137309-A1 | FUNGICIDES PHENYL-PYRIMIDNYL-AMINO DERIVATIVES | CYP1A1, CYP1A2, PAH | CAMK2D 3935/4885ABL1 268/4885BCR 2868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.